Long-term data on efficacy and safety of adalimumab in Behçet's disease

Autor: van der Houwen, T.B., Humer, B., Missotten, T.O., Thiadens, A.A.H.J., van Hagen, P.M., van Laar, J.A.M.
Zdroj: In Clinical Immunology February 2023 247
Databáze: ScienceDirect